BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Week in Review: Hutchison Medipharma Partners Cancer Drug With Eli Lilly and Company (LLY)


10/14/2013 7:49:29 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

October 12, 2013 -- Hutchison MediPharma, a Chi-Med subsidiary, will partner its cancer drug fruquintinib with Lilly in a deal potentially worth $86.5 million; ASLAN Pharma of Singapore completed a Series B financing that brought in $22 million; Eddingpharm acquired China rights to Immutep’s ImmunFact IMP321, an immuno-treatment for breast cancer; Shenzhen Chipscreen Biosciences out-licensed Taiwanese rights for a cancer drug candidate to a Taiwanese startup; Sihuan Pharma received CFDA approval to begin clinical trials of pirotinib, an innovative cancer drug; a vaccine for Japanese encephalitis developed by China National Biotec was prequalified by the World Health Organization; Hutchison MediPharma will receive a $6 million milestone payment from Janssen Pharma in an inflammation drug partnership; two scientists formerly employed by Eli Lilly were indicted for passing proprietary information to an employee of Jiangsu Hengrui Medicine; and China police have arrested another suspect in the GlaxoSmithKline bribery case. More details….

Stock Symbol: (AIM: HCM) (NYSE: LLY) (HK: 0460) (NYSE: GSK)

Help employers find you! Check out all the jobs and post your resume.


Read at ChinaBio Today

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES